This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, T. S.
Right arrow Articles by Nick, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, T. S.
Right arrow Articles by Nick, J. A.

 Previous Article  |  Next Article 

Infection and Immunity, June 2005, p. 3693-3701, Vol. 73, No. 6
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.6.3693-3701.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Enhanced Pseudomonas aeruginosa Biofilm Development Mediated by Human Neutrophils

Travis S. Walker,1 Kerry L. Tomlin,1 G. Scott Worthen,1,2 Katie R. Poch,1 Jonathan G. Lieber,1 Milene T. Saavedra,2 Michael B. Fessler,1,2 Kenneth C. Malcolm,1 Michael L. Vasil,3 and Jerry A. Nick1,2*

Department of Medicine, National Jewish Medical and Research Center, 1400 Jackson Street, D202, Denver, Colorado 80206,1 Division of Pulmonary Science and Critical Care Medicine,2 Department of Microbiology and Immunology, University of Colorado School of Medicine, 4200 E. Ninth Avenue, Denver, Colorado 802623

Received 1 October 2004/ Returned for modification 18 November 2004/ Accepted 20 January 2005

Cystic fibrosis (CF) lung disease features persistent neutrophil accumulation to the airways from the time of infancy. CF children are frequently exposed to Pseudomonas aeruginosa, and by adulthood, 80% of CF patients are chronically infected. The formation of biofilms is a particularly important phenotypic characteristic of P. aeruginosa that allows for bacterial survival despite aggressive antibiotic therapy and an exuberant immune response. Here, we show that the presence of neutrophils enhances initial P. aeruginosa biofilm development over a period of 72 h through the formation of polymers comprised of actin and DNA. F-actin was found to be a site of attachment for P. aeruginosa. These actin and DNA polymers are present in CF sputum, and disruption of the polymers dispersed the associated P. aeruginosa cells and reduced biofilm development. These findings demonstrate a potential maladaptation of the primary innate response. When the host fails to eradicate the infection, cellular components from necrotic neutrophils can serve as a biological matrix to facilitate P. aeruginosa biofilm formation.

* Corresponding author. Mailing address: National Jewish Medical and Research Center, D202, 1400 Jackson Street, Denver, CO 80206. Phone: (303) 398-1579. Fax: (303) 398-1806. E-mail: nickj{at}njc.org.

Editor: J. N. Weiser

Infection and Immunity, June 2005, p. 3693-3701, Vol. 73, No. 6
0019-9567/05/$08.00+0     doi:10.1128/IAI.73.6.3693-3701.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Leid, J. G., Kerr, M., Selgado, C., Johnson, C., Moreno, G., Smith, A., Shirtliff, M. E., O'Toole, G. A., Cope, E. K. (2009). Flagellum-Mediated Biofilm Defense Mechanisms of Pseudomonas aeruginosa against Host-Derived Lactoferrin. Infect. Immun. 77: 4559-4566 [Abstract] [Full Text]  
  • Schooling, S. R., Hubley, A., Beveridge, T. J. (2009). Interactions of DNA with Biofilm-Derived Membrane Vesicles. J. Bacteriol. 191: 4097-4102 [Abstract] [Full Text]  
  • Weimer, E. T., Lu, H., Kock, N. D., Wozniak, D. J., Mizel, S. B. (2009). A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa. Infect. Immun. 77: 2356-2366 [Abstract] [Full Text]  
  • Parks, Q. M., Young, R. L., Poch, K. R., Malcolm, K. C., Vasil, M. L., Nick, J. A. (2009). Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J Med Microbiol 58: 492-502 [Abstract] [Full Text]  
  • Downey, D G, Bell, S C, Elborn, J S (2009). Neutrophils in cystic fibrosis. Thorax 64: 81-88 [Abstract] [Full Text]  
  • Wartha, F., Henriques-Normark, B. (2008). ETosis: A Novel Cell Death Pathway. Sci Signal 1: pe25-pe25 [Abstract] [Full Text]  
  • Broughton-Head, V. J., Shur, J., Carroll, M. P., Smith, J. R., Shute, J. K. (2007). Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L1240-L1249 [Abstract] [Full Text]  
  • Bucki, R., Sostarecz, A. G., Byfield, F. J., Savage, P. B., Janmey, P. A. (2007). Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum. J Antimicrob Chemother 60: 535-545 [Abstract] [Full Text]  
  • Jurcisek, J. A., Bakaletz, L. O. (2007). Biofilms Formed by Nontypeable Haemophilus influenzae In Vivo Contain both Double-Stranded DNA and Type IV Pilin Protein. J. Bacteriol. 189: 3868-3875 [Abstract] [Full Text]  
  • Chandra, J., McCormick, T. S., Imamura, Y., Mukherjee, P. K., Ghannoum, M. A. (2007). Interaction of Candida albicans with Adherent Human Peripheral Blood Mononuclear Cells Increases C. albicans Biofilm Formation and Results in Differential Expression of Pro- and Anti-Inflammatory Cytokines. Infect. Immun. 75: 2612-2620 [Abstract] [Full Text]  
  • Martinez, L. R., Casadevall, A. (2006). Cryptococcus neoformans Cells in Biofilms Are Less Susceptible than Planktonic Cells to Antimicrobial Molecules Produced by the Innate Immune System.. Infect. Immun. 74: 6118-6123 [Abstract] [Full Text]  
  • Allard, J. B., Poynter, M. E., Marr, K. A., Cohn, L., Rincon, M., Whittaker, L. A. (2006). Aspergillus fumigatus Generates an Enhanced Th2-Biased Immune Response in Mice with Defective Cystic Fibrosis Transmembrane Conductance Regulator. J. Immunol. 177: 5186-5194 [Abstract] [Full Text]  
  • Tirouvanziam, R., Conrad, C. K., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., Herzenberg, L. A. (2006). High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis. Proc. Natl. Acad. Sci. USA 103: 4628-4633 [Abstract] [Full Text]  
  • van Heeckeren, A. M., Schluchter, M. D., Xue, W., Davis, P. B. (2006). Response to Acute Lung Infection with Mucoid Pseudomonas aeruginosa in Cystic Fibrosis Mice. Am. J. Respir. Crit. Care Med. 173: 288-296 [Abstract] [Full Text]  
  • Lee, B., Haagensen, J. A. J., Ciofu, O., Andersen, J. B., Hoiby, N., Molin, S. (2005). Heterogeneity of Biofilms Formed by Nonmucoid Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis. J. Clin. Microbiol. 43: 5247-5255 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»